-
1 Comment
Sino Medical Sciences Technology Inc is currently in a long term downtrend where the price is trading 18.3% below its 200 day moving average.
From a valuation standpoint, the stock is 4.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 10.1.
Sino Medical Sciences Technology Inc's total revenue sank by 21.6% to $99M since the same quarter in the previous year.
Its net income has dropped by 27.2% to $18M since the same quarter in the previous year.
Finally, its free cash flow grew by 108.9% to $24M since the same quarter in the previous year.
Based on the above factors, Sino Medical Sciences Technology Inc gets an overall score of 1/5.
Exchange | SHG |
---|---|
CurrencyCode | CNY |
Sector | Healthcare |
Industry | Medical Devices |
ISIN | CNE100003NY2 |
Market Cap | 4B |
---|---|
PE Ratio | 485.0 |
Target Price | 14 |
Beta | 0.5 |
Dividend Yield | None |
Sino Medical Sciences Technology Inc., a medical device company, engages in the research, development, production, and distribution of interventional devices in China. Its products include coronary drug stents, coronary balloons, intracranial rapid exchange balloons, and intracranial drug-eluting stents. The company was founded in 2007 and is headquartered in Tianjin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 688108.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025